Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Long-Term Investments (2019)

Vanda Pharmaceuticals' Long-Term Investments history spans 2 years, with the latest figure at $61.8 million for Q3 2019.

  • For Q3 2019, Long-Term Investments changed N/A year-over-year to $61.8 million; the TTM value through Sep 2019 reached $61.8 million, changed N/A, while the annual FY2011 figure was $19.0 million, N/A changed from the prior year.
  • Long-Term Investments for Q3 2019 was $61.8 million at Vanda Pharmaceuticals, up from $12.5 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $61.8 million in Q3 2019 and bottomed at $12.5 million in Q2 2019.